Venture Investors
Venture Capital
Active
Madison, United States
104
12M
55
2.48
33
0.47
21
- Stages of investment
- Areas of investment
Summary
In 1982 was created Venture Investors, which is appeared as VC. The leading representative office of defined VC is situated in the Madison. The venture was found in North America in United States.
The top amount of exits for fund were in 2016. The real fund results show that this VC is 35 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Venture Investors works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Venture Investors, startups are often financed by Wisconsin Alumni Research Foundation, Novartis Venture Fund, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Wisconsin Investment Partners, Novartis Venture Fund, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Wisconsin Investment Partners, Wisconsin Alumni Research Foundation, Triathlon Medical Venture Partners.
The fund was created by John Neis, Roger Ganser. The overall number of key employees were 4.
Among the most popular portfolio startups of the fund, we may highlight Juventas Therapeutics, Alfalight, FluGen. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Manufacturing. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- 250K — 3M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 75000000
- Fund raised date
- 2019-10-02
Analytics
- Total investments
- 104
- Lead investments
- 33
- Exits
- 21
- Rounds per year
- 2.48
- Follow on index
- 0.47
- Investments by industry
- Health Care (59)
- Biotechnology (51)
- Medical Device (31)
- Medical (30)
- Therapeutics (20) Show 62 more
- Investments by region
-
- United States (104)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 39M
- Group Appearance index
- 0.84
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.46
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
AGTools | 08 Sep 2020 | Software, Information Technology, Blockchain, Agriculture | Seed | 20K | United States, California, Irvine |
EarliTec Diagnostics | 02 Apr 2024 | Health Care, Children | Early Stage Venture | 21M | United States, Georgia, Decatur |
NeuWave Medical | 05 Sep 2012 | Health Care, Manufacturing, Medical Device | Early Stage Venture | 14M | United States, Wisconsin, Madison |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.